KBI Biopharma Invests $150 Million in Right to Work North Carolina


KBI Biopharma is building a new manufacturing location in Research Triangle Park, North Carolina. In order to cover this, they plan to make a $150 million investment. In addition, they also plan to hire 200 new people for quality assurance and technical jobs. They should be ready to begin productions as soon as early 2022. So this will be great for the economy overall.

From Area Development Magazine:

“Expansion of our US-based cell culture operations is a key investment to support our clients’ commercialization strategies. […] This state-of-the-art facility will leverage the latest innovation in automation and digitalization to best meet the needs for our clients.” […]

“KBI has helped to advance more than 300 molecules in more than 70 unique indications. By expanding our commercial manufacturing footprint with this facility, we are able to provide our partners with launch material and market supply. […]

“We chose to build this new facility in the Research Triangle Park because it gives us access to highly-specialized resources. The combination of talent, technical and academic training in this region is outstanding, which is critical as we are expanding our impact by serving more clients and patients from this new facility.”


To read more updates on Right to Work states, click here.